ELAB.NASDAQElevai Labs INC

DEF 14C: PMGC Secures $20M Equity Line, Warns of Share Dilution

Sentiment:

Equity Line of Credit Announcement


PMGC Holdings Inc. has secured an equity line of credit for up to $20 million, approved by majority shareholders, which will result in significant dilution for existing common stockholders.

Capital raiseThe company entered into a Securities Purchase Agreement for an Equity Line of Credit (ELOC) with an investor, providing access to up to $20,000,000 in capital.An Initial Pre-Paid Purchase of $5,000,000 was made, resulting in net proceeds of $3,990,000 to the company.The ELOC allows for future Pre-Paid Purchases, each for a minimum of $250,000 and a maximum of $5,000,000 (less outstanding balance).The investor has a 'Participation Right' to invest in up to 25% of any future debt or equity financings by the company.
Worse than expectedThe financing terms are highly dilutive for existing common shareholders, with shares issued at a significant discount to market price (88% of lowest 10-day VWAP, with a $1.058 floor).The initial capital infusion of $5,000,000 yields only $3,990,000 in net proceeds to the company after substantial discounts and fees, indicating a high cost of capital.The company granted a first-position security interest in its subsidiaries' assets and equity, which is a significant concession and risk for the company.The extensive list of 'Events of Default' and severe penalties (15% balance increase, 18% interest) upon default place the company in a vulnerable position.

Summary

  • The company entered into a Securities Purchase Agreement with an investor for an Equity Line of Credit (ELOC) facility, allowing for the issuance and sale of common stock up to an aggregate purchase amount of $20,000,000.
  • The initial Pre-Paid Purchase under this facility was for an original principal amount of $5,000,000, from which the company received net proceeds of $3,990,000 after deducting a $425,000 original issue discount, $30,000 for investor transaction expenses, and other fees.
  • At the initial closing, 56,700 Commitment Shares and 10,300 Pre-Delivery Shares were issued to the investor, with $6.70 paid for the initial Pre-Delivery Shares.
  • The potential issuance of shares under the ELOC, which exceeds Nasdaq Listing Rule 5635(d) requirements, was approved by written consent of shareholders owning 90.41% of the company's total voting power as of September 16, 2025.
  • The investor has the right to purchase additional common shares at 88.00% of the lowest Volume Weighted Average Price (VWAP) during a 10-trading day period, with a floor price of $1.058 per share, or elect cash payment if the price falls below this floor.
  • The company is required to reserve 8,000,000 common shares for issuance under the agreement and must file a Form S-1 registration statement for their resale within 30 days of the initial closing.
  • The company's obligations under the Pre-Paid Purchases are secured by a first-position security interest in the assets and equity interests of its wholly-owned subsidiaries, AGA Precision Systems LLC and Pacific Sun Packaging Inc.
  • The investor holds a participation right to invest in up to 25% of any future debt or equity financings by the company and is subject to a weekly sales cap of 15% of the total weekly dollar trading volume of common stock.

Sentiment

Score: 3

Explanation: The filing indicates a necessary capital raise but on highly unfavorable terms for existing shareholders, including significant dilution, high costs, and substantial investor protections. While capital is secured, the long-term implications for shareholder value are negative.

Positives

  • Secured access to up to $20,000,000 in capital through an equity line of credit, providing financial flexibility for operations and strategic initiatives.
  • The financing mechanism allows the company to draw capital as needed, potentially reducing immediate large-scale dilution compared to a single large offering.

Negatives

  • Significant potential for dilution of existing common stockholders' voting power, earnings per share, liquidation rights, and book/market value.
  • The initial capital infusion of $5,000,000 yields only $3,990,000 in net proceeds to the company after substantial discounts ($425,000 OID) and fees ($30,000 transaction expenses, plus other legal and placement agent fees), indicating a high cost of capital.
  • The investor can purchase shares at a significant discount (88% of lowest 10-day VWAP) and has a floor price of $1.058, which could be substantially below the market price at the time of issuance.
  • The company's obligations are secured by a first-position security interest in the assets and equity interests of its wholly-owned subsidiaries, AGA Precision Systems LLC and Pacific Sun Packaging Inc., which is a significant concession.
  • Extensive Event of Default conditions, which can trigger immediate acceleration of the outstanding balance by 15% and an 18% annual interest rate, placing the company in a vulnerable position.
  • The investor holds a 'Participation Right' to invest in up to 25% of future debt or equity financings, potentially limiting the company's options for other capital raises or strategic partnerships.
  • Majority shareholder approval by written consent bypassed a general shareholder meeting, limiting broader shareholder input on a highly dilutive transaction.

Risks

  • Shareholder Dilution: Issuance of shares under the ELOC will dilute shareholder voting power, potential earnings per share, liquidation rights, and may reduce the book and market value of common stock.
  • Default Risk: Numerous 'Events of Default' conditions, including failure to pay, insolvency, failure to maintain share reserve, or breaches of covenants, could lead to immediate acceleration of the outstanding balance and significant penalties (15% increase, 18% interest).
  • Security Interest: The company's obligations are secured by a first-position security interest in the assets and equity interests of its wholly-owned subsidiaries, AGA Precision Systems LLC and Pacific Sun Packaging Inc., posing a risk to core assets.
  • Market Price Volatility: The purchase price for shares is tied to VWAP, which could incentivize the investor to sell shares, potentially increasing market volatility and downward pressure on the stock price.
  • Limited Future Financing Flexibility: Covenants restrict the company from entering into certain variable rate transactions or issuing other securities without investor consent, potentially hindering future capital raises or strategic partnerships.
  • Arbitration and Venue: Disputes are subject to binding arbitration in Salt Lake County, Utah, and parties waive jury trial rights, which may limit legal recourse options.

Future Outlook

The company anticipates using the capital from the equity line of credit to support its operations and strategic initiatives. It plans to file a Form S-1 registration statement to allow for the resale of shares issued under the agreement and will continue to comply with SEC reporting requirements.

Management Comments

  • We are not asking you for a proxy and you are requested not to send us a proxy.
  • This Information Statement is being furnished to you solely for the purpose of informing shareholders of the matters described herein pursuant to Section 14(c) of the Exchange Act and the regulations promulgated thereunder, including Regulation 14C, and no shareholders meeting will be held to consider the matters described herein.
  • By Order of the Board of Directors, /s/ Braeden Lichti, Non-Employee, Non-Executive Chairman of the Board of Directors.

Industry Context

This equity line of credit provides PMGC Holdings Inc. with a flexible financing mechanism, common for smaller public companies seeking capital without immediate large-scale equity offerings. However, the terms, including significant discounts and investor protections, suggest a challenging capital-raising environment or a company with limited alternative financing options. The substantial dilution potential is a common trade-off in such arrangements, often seen in growth-stage companies or those requiring operational funding.

Comparison to Industry Standards

  • The 88% of lowest 10-day VWAP purchase price is a significant discount, often seen in highly dilutive equity lines of credit, which are generally considered less favorable than traditional equity raises or non-dilutive debt.
  • The 120% prepayment penalty and 18% default interest rate are high, indicating a costly financing structure compared to standard corporate debt.
  • The granting of a first-position security interest in subsidiary assets and equity is a strong protection for the investor, typically seen in higher-risk lending or when the company's creditworthiness is a concern.
  • The investor's participation right in future financings (25%) is a common feature in such agreements but can limit the company's flexibility to secure more favorable terms from other investors in the future.
  • The use of written consent by majority shareholders to approve a highly dilutive transaction, bypassing a general meeting, while legally permissible, can be viewed negatively from a corporate governance perspective compared to broader shareholder engagement.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Shareholder Approval MethodThe ELOC Share Issuance Approval was obtained through written consent of Majority Shareholders (90.41% voting power) instead of a formal shareholder meeting, as permitted by Nevada Revised Statutes and company bylaws.September 16, 2025This method bypasses broader shareholder discussion and voting, potentially limiting transparency and direct input from minority shareholders on a highly dilutive transaction.
Investor Rights and ProtectionsThe company granted the investor extensive rights, including a first-position security interest in subsidiary assets, a participation right in future financings, and strict covenants restricting other capital raises without investor consent.September 23, 2025These provisions significantly empower the investor and could constrain the company's future strategic and financial flexibility, potentially impacting corporate autonomy.
Dispute ResolutionAll claims and disputes arising from the transaction documents are subject to binding arbitration in Salt Lake County, Utah, with a waiver of jury trial rights.September 23, 2025This centralizes dispute resolution but limits the company's and other stakeholders' access to traditional court systems and jury trials for potential grievances.

Related Party Transactions

  • The 'Majority Shareholders' who approved the ELOC Share Issuance include Braeden Lichti (Non-employee, Non-executive Chairman) and Graydon Bensler (Non-employee CEO, CFO, and Director), through entities they wholly own (Northstrive Companies Inc. and GB Capital Ltd, respectively).
  • These individuals and their entities collectively held 90.41% of the total voting power as of the Record Date, indicating significant insider control over the approval of this transaction.

Stakeholder Impact

  • Shareholders: Significant dilution of voting power, potential earnings per share, liquidation rights, and book/market value of common stock. Minority shareholders have limited recourse due to majority consent.
  • Employees: No direct impact mentioned, but securing capital could support continued operations and job security.
  • Customers/Suppliers: No direct impact mentioned, but improved financial stability from capital raise could ensure continuity of business relationships.
  • Creditors: The investor gains a first-position security interest in key subsidiary assets, potentially subordinating other unsecured creditors in a default scenario.

Next Steps

  • Company to file a registration statement on Form S-1 within 30 days of the Initial Closing Date (September 26, 2025) to register at least 5,000,000 common shares for resale.
  • Company to file a current report on Form 8-K within four business days after the execution of the Initial Pre-Paid Purchase (September 26, 2025).
  • Company to file the definitive Information Statement on Schedule 14C no later than 20 calendar days following the Initial Closing Date (September 26, 2025).
  • The ELOC Share Issuance Approval will be implemented 20 calendar days after the Information Statement is first mailed to shareholders (October 10, 2025).
  • Company to use reasonable best efforts to cause the Initial Registration Statement to be deemed effective by the SEC as soon as possible.
  • Company to reserve 8,000,000 common shares initially, and add increments of 100,000 shares to the Share Reserve as requested by the Investor under certain conditions.

Key Dates

DateDescription
September 16, 2025Record Date for outstanding common and Series B preferred stock; Majority Shareholders adopted resolutions authorizing the ELOC Share Issuance Approval.
September 23, 2025Date of the Securities Purchase Agreement between the Company and the Investor; Closing price of common stock on Nasdaq was $5.29 per share.
September 26, 2025Initial Pre-Paid Purchase delivered to the Investor; Initial Closing Date for the transaction; Maturity date of the Initial Pre-Paid Purchase (3 years from this date).
October 10, 2025Information Statement first mailed to shareholders.
20 calendar days after October 10, 2025ELOC Share Issuance Approval will be implemented.
Within 4 business days after September 26, 2025Company to file a current report on Form 8-K relating to the transactions.
No later than 20 calendar days following September 26, 2025Company to file the definitive Information Statement on Schedule 14C.
Within 30 days from September 26, 2025Company to file a registration statement on Form S-1 for resale of shares.

Recommendation

strong sell

The terms of this equity line of credit are highly unfavorable for existing common shareholders. The significant potential for dilution, the substantial discount at which shares can be purchased by the investor (88% of lowest 10-day VWAP), the high cost of capital (OID, fees, default penalties), and the granting of a first-position security interest in core subsidiary assets collectively indicate a distressed financing arrangement. While it provides capital, the long-term value erosion for current shareholders is substantial, making it a strong sell recommendation.

Keywords

Equity Line of Credit, ELOC, Share Dilution, SEC Filing, DEF 14C, PMGC Holdings Inc., Nasdaq Listing Rule 5635(d), Securities Purchase Agreement, Pre-Paid Purchase, Corporate Governance, Shareholder Approval, Security Interest, Risk Management, Financial Reporting, Investment, Capital Raise

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.